Enanta's RSV treatment misses main goal in mid-stage study-February 2024-www.financetom.com

Enanta's RSV treatment misses main goal in mid-stage study

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Enanta's RSV treatment misses main goal in mid-stage study

Sep 29, 2025 4:05 AM

Sept 29 (Reuters) - Enanta Pharmaceuticals ( ENTA ) said

on Monday its treatment for respiratory syncytial virus failed

to shorten the time taken to reduce the severity of some

symptoms, missing the primary goal of a mid-stage study.

Shares of the company were down nearly 30% in premarket

trading.

Previous page： Snowflake's Growth Prospects Have Improved Under New CEO Ramaswamy, Says Morgan Stanley Next page： Market Chatter: Senator Warren Criticizes Regulators' Potential Leverage Rule Changes for Banks

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Snowflake's Growth Prospects Have Improved Under New CEO Ramaswamy, Says Morgan Stanley

Jun 24, 2025

10:41 AM EDT, 06/24/2025 (MT Newswires) -- Snowflake's (SNOW) secular growth prospects have improved under the leadership of Chief Executive Sridhar Ramaswamy, who took over the role in February 2024, Morgan Stanley said in a note Tuesday. Building on this, Morgan Stanley said the pace of product innovation at Snowflake has accelerated materially across its four major opportunities, which include...

Market Chatter: Senator Warren Criticizes Regulators' Potential Leverage Rule Changes for Banks

Jun 24, 2025

10:43 AM EDT, 06/24/2025 (MT Newswires) -- US Senator Elizabeth Warren has criticized banking regulators' potential changes to the enhanced supplementary leverage ratio for banks, Bloomberg reported Tuesday, citing a letter that the lawmaker wrote to the regulators. The changes, which include cutting a bank holding company's capital requirement under the rule to a 3.5% to 4.5% range from the...

FactSet's New CEO Expected to 'Accelerate' Investments, Reset Fiscal 2026 Margin Guidance, RBC Says

Jun 24, 2025

10:44 AM EDT, 06/24/2025 (MT Newswires) -- FactSet Research Systems' ( FDS ) new chief executive is expected to accelerate investments and reset fiscal 2026 margin outlook as the company's focus will be on the strategic priorities in the future, RBC said in a Monday note. The company demonstrated a strong pipeline for fiscal Q4 for its organic annual subscription...

Google agrees $36 million fine for anti-competitive deals with Australia telcos

Aug 17, 2025

SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...